| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1996;112:1098-1107
© 1996 Mosby, Inc.
CARDIOPULMONARY BYPASS, |
Received for publication Jan. 22, 1996 Revisions requested March 13, 1996; revisions received April 23, 1996 Accepted for publication June 4, 1996. Address for reprints: Thomas J. Vander Salm, MD, Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue, N. Worcester, MA 01655-0333.
Abstract
Excessive postoperative bleeding after heart operations continues to be a source of morbidity. This prospective double-blind study evaluated epsilon-aminocaproic acid as an agent to reduce postoperative bleeding and investigated its mode of action. One hundred three patients were randomly assigned to receive either 30 gm epsilon-aminocaproic acid (51 patients) or an equivalent volume of placebo (52 patients). In a subset of these patients (14 epsilon-aminocaproic acid, 12 placebo), tests of platelet function and fibrinolysis were performed.Results: By multivariate analysis, three factors were associated with decreased blood loss in the first 24 hours after operation: epsilon-aminocaproic acid versus placebo (647 ml versus 839 ml, p = 0.004), surgeon 1 versus all other surgeons (582 ml versus 978 ml,p = 0.002), and no intraaortic balloon versus intraaortic balloon pump use (664 ml versus 1410 ml,p = 0.02). No significant differences in platelet function could be demonstrated between the two groups. Inhibited fibrinolysis, as reflected by less depression of the euglobulin clot lysis and no rise in d-dimer levels, was significant in the epsilon-aminocaproic acid group compared with the placebo group.Conclusion: The intraoperative use of epsilon-aminocaproic acid reduces postoperative cardiac surgical bleeding. (J THORAC CARDIOVASC SURG 1996;112:1098-107)
This article has been cited by other articles:
|
|
 |
|
  J. D. Eubanks Antifibrinolytics in Major Orthopaedic Surgery J. Am. Acad. Ortho. Surg., March 1, 2010; 18(3): 132 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Greilich, M. E. Jessen, N. Satyanarayana, C. W. Whitten, G. A. Nuttall, J. M. Beckham, M. H. Wall, and J. F. Butterworth The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial Anesth. Analg., July 1, 2009; 109(1): 15 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery Circulation, June 5, 2007; 115(22): 2801 - 2813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Mannucci and M. Levi Prevention and Treatment of Major Blood Loss N. Engl. J. Med., May 31, 2007; 356(22): 2301 - 2311. [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Mossad, S. Machado, and J. Apostolakis Bleeding following deep hypothermia and circulatory arrest in children. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 34 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Dial, E. Delabays, M. Albert, A. Gonzalez, J. Camarda, A. Law, and D. Menzies Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 654 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Morawski, M. Sanak, M. Cisowski, M. Szczeklik, W. Szczeklik, J. Dropinski, T. Waclawczyk, R. Ulczok, and A. Bochenek Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 791 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Ballen, P. S. Becker, B. Y. Yeap, B. Matthews, D. H. Henry, and P. A. Ford Autologous Stem-Cell Transplantation Can Be Performed Safely Without the Use of Blood-Product Support J. Clin. Oncol., October 15, 2004; 22(20): 4087 - 4094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Grocott, J. A. Clark, H. M. Homi, and A. Sharma "Other" Neurologic Complications After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 213 - 226. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Eisses, K. Seidel, G. S. Aldea, and W. L. Chandler Reducing Hemostatic Activation During Cardiopulmonary Bypass: A Combined Approach Anesth. Analg., May 1, 2004; 98(5): 1208 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Wijeysundera, W. S. Beattie, V. Rao, J. Ivanov, and K. Karkouti Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 755 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Wijeysundera, W. S. Beattie, V. Rao, and J. Karski Calcium antagonists reduce cardiovascular complications after cardiac surgery: A meta-analysis J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1496 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Quin, M. P. Tauriainen, L. M. Huber, D. D. McIntire, P. A. Kaiser, W. S. Ring, and M. E. Jessen Predictors of pericardial effusion after orthotopic heart transplantation J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 979 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Nzerue and B. Falana Refractory hyperkalaemia associated with use of epsilon-aminocaproic acid during coronary bypass in a dialysis patient Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1150 - 1151. [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stafford-Smith, B. Phillips-Bute, D. N. Reddan, J. Black, and M. F. Newman The Association of {epsilon}-Aminocaproic Acid with Postoperative Decrease in Creatinine Clearance in 1502 Coronary Bypass Patients Anesth. Analg., October 1, 2000; 91(5): 1085 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Casati, D. Guzzon, M. Oppizzi, M. Cossolini, G. Torri, G. Calori, and O. Alfieri Hemostatic effects of aprotinin, tranexamic acid and {epsilon}-aminocaproic acid in primary cardiac surgery Ann. Thorac. Surg., December 1, 1999; 68(6): 2252 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF]
|
|
|
|
|
|
G. D. Williams, S. L. Bratton, and C. Ramamoorthy Factors Associated with Blood Loss and Blood Product Transfusions: A Multivariate Analysis in Children After Open-Heart Surgery Anesth. Analg., July 1, 1999; 89(1): 57 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Munoz, N. J. O. Birkmeyer, J. D. Birkmeyer, G. T. O'Connor, and L. J. Dacey Is {epsilon}-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? : A Meta-Analysis Circulation, January 12, 1999; 99(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Savarese, H. Waitkus, F. M. Stewart, and M. Callery Bloodless Medicine and Surgery J Intensive Care Med, January 1, 1999; 14(1): 20 - 33. [PDF]
|
|
|
|
|
|
P. M. Mannucci Hemostatic Drugs N. Engl. J. Med., July 23, 1998; 339(4): 245 - 253. [Full Text] [PDF]
|
|
|
|
|
|
M. P. Pelletier, S. Solymoss, A. Lee, and R. C.-J. Chiu Negative Reexploration for Cardiac Postoperative Bleeding: Can It Be Therapeutic? Ann. Thorac. Surg., April 1, 1998; 65(4): 999 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Eberle, E. Mayer, G. Hafner, J. Heinermann, M. Dahm, W. Prellwitz, W. Dick, and H. Oelert High-Dose {epsilon}-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations Ann. Thorac. Surg., March 1, 1998; 65(3): 667 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Vander Salm Use of epsilon-aminocaproic acid to reduce bleeding J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1126 - 1127. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
